PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI

PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI

Bibliographic Details
Main Authors:	Silvia Marce Torra, Aleix Méndez, Antonella Luciana Sturla, Miriam Ratia, Anna Angona Figueras, Paula Amat, Francisca Ferrer-Marín, Silvia Escribano, Emilia Scalzulli, Montserrat Cortes Sansa, Esther Plensa, Natalia Estrada, Marta Cabezon Marco, Mireia Morgades, Maria Alicia Senin Magan, Juan Carlos Hernandez-Boluda, Eduardo Anguita, Massimo Breccia, Valentín García-Gutiérrez, Blanca Xicoy Cirici, Lurdes Zamora
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d

Similar Items

e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
by: Sílvia Marcé, et al.
Published: (2024-01-01)

P690: GENE MUTATIONAL PROFILE ASSOCIATED WITH TREATMENT FAILURE OR PROGRESSION IN CHRONIC MYELOID LEUKEMIA
by: N. Estrada, et al.
Published: (2022-06-01)

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia
by: Matteo Molica, et al.
Published: (2019-02-01)

P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE
by: N. P. Shah, et al.
Published: (2022-06-01)

Nilotinib after resistance to imatinib in CML patients with Wolf-Parkinson White syndrome
by: Massimo Breccia
Published: (2015-10-01)

Molecular Monitoring of Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
by: Mehrdad Payandeh, et al.
Published: (2018-12-01)

Molecular monitoring of Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
by: saba yari
Published: (2018-12-01)

Increased circulating Tfh to Tfr ratio in chronic renal allograft dysfunction: a pilot study
by: Lin Yan, et al.
Published: (2019-08-01)

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)
by: Mehrdad Payandeh, et al.
Published: (2014-12-01)

Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)
by: Rabia Khalid, et al.
Published: (2023-12-01)

Chronic myeloid leukemia (CML): prognostic factors and survival analysis
by: Gisele Wally Braga, et al.

Identifying regulators of chronic myeloid leukaemic (CML) stem cell quiescence and discovering effective novel therapies for CML relapse
by: Xu, Z
Published: (2022)

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
by: Natalia Estrada, et al.
Published: (2021-12-01)

BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS FOR CML IN CHRONIC PHASE
by: Cullis, J, et al.
Published: (1991)

Targeting a chronic problem: elimination of cancer stem cells in CML.
by: Nerlov, C
Published: (2009)

Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)
by: C. B. Almeida, et al.
Published: (2016-11-01)

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib
by: Sílvia Marcé, et al.
Published: (2021-07-01)

P713: REAL-WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML
by: G. Nesr, et al.
Published: (2022-06-01)

Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
by: Rebecca Faresjö, et al.
Published: (2023-05-01)

BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CML - THE ROLE OF T-CELL DEPLETION IN 1988
by: Mackinnon, S, et al.
Published: (1988)

P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML
by: A. Bidikian, et al.
Published: (2022-06-01)

PENGARUH GIZI TERHADAP RESPON TERAPI PASIEN CHRONIC MYELOCYSTIC LEUKIMIA (CML)
by: Asrini Safitri, et al.
Published: (2018-10-01)

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients
by: Fahri Sahin, et al.
Published: (2013-09-01)

TFR for males in Denmark: Calculation and tempo-correction
by: Francisca Nordfalk, et al.
Published: (2015-06-01)

The extrahepatic role of TFR2 in iron homeostasis
by: Laura eSilvestri, et al.
Published: (2014-05-01)

TFR Predictions Based on Brownian Motion Theory
by: Keilman Nico
Published: (2002-01-01)

P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIAN, MULTI-RESISTANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENT POPULATION
by: Massimo Breccia, et al.
Published: (2023-08-01)

Treatment and long-term follow-up of children with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Experience from the Tata Memorial Hospital pediatric CML cohort over 2 decades
by: Nirmalya Roy Moulik, et al.
Published: (2022-01-01)

P667: RISK OF PROGRESSION IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA PATIENTS ELIGIBLE FOR TYROSINE KINASE INHIBITOR DISCONTINUATION: FINAL ANALYSIS OF THE TFR-PRO STUDY
by: Giovanni Paolo Maria Zambrotta, et al.
Published: (2023-08-01)

P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS
by: S. Saußele, et al.
Published: (2022-06-01)

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
by: A. Iurlo, et al.
Published: (2023-03-01)

Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
by: Young Kwang Chae, et al.
Published: (2008-07-01)

Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
by: Ibrahim C. Haznedaroglu
Published: (2014-08-01)

Penurunan TFR baik untuk negara penduduk padat
by: Berita Harian
Published: (2022)

Triptolide regulates the balance of Tfr/Tfh in lupus mice
by: Xia Zhao, et al.
Published: (2023-07-01)

Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms
by: Daniela Zizioli, et al.
Published: (2021-02-01)

Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
by: Michael Daskalakis, et al.
Published: (2021-12-01)

BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS
by: Mackinnon, S, et al.
Published: (1988)

BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS
by: Mackinnon, S, et al.
Published: (1988)

PB1973: MOLECULAR PATTERNS OF RESPONSE AFTER FRONTLINE TREATMENT IN CHRONIC MYELOID LEUKAEMIA (CML).
by: Harberth Fernandez-Leyva
Published: (2023-08-01)